The analysis revealed that Day 30 represents the peak of functional maturity, marked by the highest expression of key-metabolizing enzymes, such as cytochrome P450 3A4 (CYP3A4), along with cholangiocyte-specific proteins and hepatic metabolic enzymes
Its once-weekly dosing improves patient adherence, while strong clinical outcomes and widespread physician adoption further support its market leadership The type 2 diabetes mellitus is expected to account for the largest share during the forecast period in application market In 2025, the type 2 diabetes mellitus segment is expected to dominate the market with the largest market share of 74.5% due to the widespread adoption of GLP-1 receptor agonists, such as Ozempic and Trulicity, for managing Type 2 diabetes
Abstract Identification of the mechanisms by which drugs of abuse cause neuronal dysfunction is essential for understanding the biological bases of their acute and long-lasting effects in the brain
By inhibiting these pathways, quercetin effectively reduces triglyceride accumulation within hepatocytes and improves overall lipid profiles
By 2035, obesity prevalence is expected to reach nearly 47% of the adult population, affecting an estimated 126 million Americans